WHat is our Offering?

RAXON is an innovative medical device kit designed to concentrate and extract anti-inflammatory proteins from patients’ own blood through Autologous Conditioned Serum (ACS). Our single-use device enables the separation of exosomes, which are tiny vesicles containing proteins that play a vital role in inflammation reduction and tissue regeneration. With the growing demand for regenerative medicine, RAXON addresses the urgent need for effective treatments across various medical fields, including orthopedics, dermatology, sports medicine, and stroke recovery.

Autologous conditioned serum

Autologous conditioned serum (ACS) is similar to platelet-rich plasma isolation except the blood sample is incubated at a slightly elevated temperature, for example, from about 18°C to about 37°C and then subjected to separation for recovery of cytokines including anti-inflammatory Interleukins. The incubation process enhances the activation of platelets and other cellular components, leading to the release of various growth factors and cytokines that play a crucial role in tissue repair and regeneration. Following incubation, the blood sample undergoes centrifugation, which effectively separates the serum from the cellular components, allowing for the concentration of beneficial solubles.

 

Autologous conditioned serum has garnered attention in various medical fields, particularly in orthopedics and sports medicine, for its potential to alleviate pain and accelerate healing in musculoskeletal injuries. By employing the natural healing properties present in a patient's own blood, ACS aims to reduce inflammation and promote the repair of damaged tissues without the risk of allergic reactions or disease transmission associated with allogenic therapies.

 

Research has shown promising results in conditions such as osteoarthritis, tendinitis, and ligament injuries, where the body’s own healing mechanisms are leveraged to enhance recovery. As understanding grows regarding the specific cytokines and growth factors released during the ACS process, tailored applications could emerge, providing even more targeted treatments for individual patients. The method holds particular allure due to its simplicity, safety profile, and the minimal preparation needed compared to more complex regenerative strategies.

 

Ongoing studies continue to evaluate the long-term effects and efficacy of autologous conditioned serum therapies, potentially paving the way for broader clinical applications and a better understanding of its role in contemporary regenerative medicine.

 

Imbalances in platelet-derived growth factors, cytokines and chemokines disrupt the healing process. The structure of inflammatory cytokines causes a cycle of tissue destruction, and the lack of a perfusion and lack of proper blood support limits wound nutrition so regeneration of wound structure and tissue matrix is not advanced.

In these patients, in addition to comprehensive wound management in terms of treatment of the cause, infection control, etc., every week, RAXON-PRP gel is applied topically to the wound and bandaged with Vaseline gas in the kit. 24 to 48 hours later (Preferably 36 hours) the gel dressing is opened and after rinsing with physiological serum, the usual care should be done until the next visit (next week). Most sources do not recommend dressing for more than 12 weeks. Evidence of clinical response is considered as the ability to produce positive results, response intensity, response time, and number of treatments to achieve a positive response.